Publication | Closed Access

Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution

ObesityMetabolic SyndromeBariatric SurgeryDiabetesPharmacologyAltered Drug DistributionObesity ManagementObese PatientsPharmacotherapyMedicineIfosfamide Elimination Half-lifeMetabolic Complication